Hypertension (HTN) is the most common chronic disease in the U.S., and the standard model of office-based care delivery has yielded suboptimal outcomes, with approximately 50% of affected patients not achieving blood pressure (BP) control. Poor population-level BP control has been primarily attributed to therapeutic inertia and low patient engagement. New models of care delivery utilizing patient-generated health data, comprehensive assessment of social Improving hypertension control in the population
Patient engagement
Hypertension (HTN) remains the most common chronic condition, affecting 30% of U.S. adults and is the leading diagnoses made during a primary care office visit. 1 In the U.S.
alone, the estimated annual cost of HTN exceeds $50 billion, and across the globe, HTN is responsible for approximately 10% of all healthcare spending. 2, 3 Roughly half of individuals with HTN have not achieved guideline-recommended blood pressure (BP) targets; as a result, HTN is one of the nation's leading causes of death, responsible for one in six deaths among adults annually. Additionally, uncontrolled HTN increases non-fatal myocardial infarction and stroke and remains the second leading cause of renal failure. Since the year 2000, HTN-related deaths in the U.S. have risen by 23% whereas all other causes of death combined over this same period have fallen by 21%. 4 Achieving improved population-based BP control remains a primary objective of public health policy and healthcare financing organizations across the globe yet efforts have been limited to minor adjustments in the current model of office-based care delivery. 5, 6 Improving hypertension control in the population
Why such a large percentage of HTN patients fail to achieve BP control remains an area of intense interest. When comparing patients with controlled versus uncontrolled HTN, routine characteristics such as age, gender, health insurance, and visit frequency are remarkably similar. In NHANES III, 92% of patients with uncontrolled HTN possessed health insurance, and 86% reported a regular source of healthcare. 7 In fact, patients with uncontrolled HTN saw their physician an average of 4.3 times per year, a frequency similar to that of patients with controlled HTN. What is noteworthy however, is in only 22%-38% of these visits was pharmacologic therapy either started or intensified. The failure to augment therapy in order to achieve disease-specific treatment goals has been coined "therapeutic inertia", and consists of three domains of responsibility: the clinician, the patient, and the healthcare system. 8 (Table 1) When evaluating patients with uncontrolled HTN, the prevalence of therapeutic inertia has been reported to be as high as 87% of provider visits, thus offering the potential for quality improvement initiatives targeting this shortcoming in clinical care. 9 This failure at the provider level can be ameliorated by use of guideline-based protocols executed by non-physician providers working in a "focused-factory" model of care delivery. 8 Organizing care utilizing specialized integrated practice units (IPUs), offers such a potential. An IPU utilizes non-physician personnel dedicated to a specific disease condition for the full cycle of care. 10, 11 Members of the care team may include pharmacists, advanced practice clinicians, nurses, health educators, dieticians, social workers, counselors and therapists, all organized around the patient's medical condition. In this model, patients can be more frequently and effectively connected to the health delivery system utilizing apps as well as home-based and wearable devices, and communication can be consistent and at regular intervals between the care team and the patient.
8 Patients can achieve a higher level of engagement in the care process via enhanced education, real-time feedback via wearable and home-based devices, and enriched communication with both the care team and other patients via social networks, thus achieving high satisfaction and improved outcomes within the healthcare system (Fig 1) .
The role of patient-generated health data in hypertension management
Home BP collection has been endorsed by many HTN guidelines, and addresses several limitations of traditional office-based care, including a larger sample of biologic data, reducing misclassification due to white-coat or masked HTN, and an ability to take more timely action and course correct therapy. [12] [13] [14] [15] Home measurements better predict cardiovascular (CV) risk than do office measurements, are more 20 Strategies that encompass patient-generated health data (PGHD) together with focused efforts to enhance patient engagement have shown efficacy in improving outcomes in chronic disease.
16,21
Phenotyping the patient with hypertension: The importance of precision medicine
Managing patients with chronic disease including HTN must include factors that play a role in achieving long-term, disease-based outcomes. These often include considerations that lie outside the traditional domain of the medical record. (Table 2 ) Based on the resulting patient phenotype, therapy and interventions can be directed that are tailored to the individual's unique circumstance. For instance, education programs and even prescription labeling can be adjusted based on health literacy, and focused interventions towards increasing patient activation can be promoted in populations with reduced medication adherence. Altering medications to generics and/or enrolling patients in patient assistance programs can help those with difficulties in paying for medicine, and inclusion of food preparers in dietary sodium education can significantly influence overall sodium consumption. All these efforts can dramatically assist in achieving BP control, and can be best achieved using an IPU model where comprehensive assessment and focused care delivery impacting lifestyle and pharmacologic management are available without the constraints of a 15-minute office visit. 
Population-directed efforts in hypertension management
Timely communication and feedback can also play a large role in population-based efforts towards HTN control. Communication can include regular progress reports towards achieving BP goals as well as tips promoting and/or reinforcing lifestyle change (Fig 2) . Communicating test results is also highly desired among patients with chronic disease and is typically mediated via a password-protected patient portal. 22 Lifestyle-focused texts offering advice, motivational reminders and support have also been shown to be effective in improving HTN and other chronic diseases. 23 Up to 40 percent of patients with chronic conditions desire medication reminders, and today, these can be easily employed using many user-friendly free apps available on smartphones and smart-watches (i.e. Apple Watch) (Fig 3) . 24 Many of these apps are interactive, providing a
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Test Patient
Hypertension Digital Medicine Report
High blood pressure, also called hypertension, occurs when the pressure inside your arteries is higher than it should be. One in three American adults has high blood pressure, and if it is not controlled, it can cause damage to your eyes, brain, heart, blood vessels and kidneys; as a result, high blood pressure is a leading cause of heart attack and stroke. High blood pressure has no warning signs or symptoms, so monitoring your blood pressure readings and getting it under control is very important to your health and well-being.
What is High Blood Pressure?
Your Results
Try these physical activities to reduce your blood pressure:
• Take your children or grandchildren to the park.
• Take a 30-minute window-shopping walk around the mall when weather is bad.
Did you know that the more alcohol you drink, the higher your blood pressure? The good news is that by reducing your alcohol intake, ideally to less than 2 alcoholic drinks per day, you can effectively lower blood pressure. means for providers to monitor medication adherence and refill needs.
Large volumes of PGHD including home BP readings can be loaded into computer algorithms within the electronic medical record that can highlight which patients need what type of support and when. This can include advice, encouragement, lifestyle tips or medication adjustment; all delivered via the IPU in near real-time. Providing this comprehensive approach to population HTN management has now been demonstrated to be more effective than routine office-based management. 25 
Recent study
In a study comparing patients with uncontrolled HTN, more patients achieved BP control within 90 days using a digital-IPU model as described, compared to those managed conventionally. Table 3 describes the changes in BP metrics and other health metrics at 90 days in the digital-IPU model (a) and usual care (b) groups. BP including systolic, diastolic, mean arterial pressure, and pulse pressure improved significantly in both groups (p < 0.001). Moreover, at 90 days, 71% of patients in the digital-IPU group achieved BP control compared to 31% of usual care patients (p < 0.001). Over the 90-day period, the usual care group had an average of 3 ± 0.2 BP recordings in the electronic medical record compared to 161 ± 150 recordings (averaging 4.2/week) in the digital-IPU group (p < 0.001), who submitted BP data directly from home to the electronic medical record.
Patients received monthly reports, text reminders, and frequent interactions with the IPU care team, made up of clinical pharmacists and health coaches. Patient activation improved overall, as reflected by a 60% reduction in percent of patients with low patient activation. It is noteworthy that the mean age of the digital medicine cohort was 68 years, suggesting that use of technology from home was not a deterrent for an elderly population.
The differences highlighted between office-based care dispersed several times per year and a more continual care model are not trivial, and were accompanied by improved quality and engagement. Additionally, this model of precision-based, highly interactive care is cost-effective and is applicable across broad populations regardless of geographic distribution.
Conclusion
HTN management using an office-based model of care delivery has demonstrated suboptimal results in population level BP control, patient engagement, and HTN-related clinical outcomes. New models of care delivery, incorporating PGHD, high levels of patient connectivity and communication, tailored interventions incorporating individual social determinants, all administered through an IPU model, has been demonstrated to yield superior BP control, while at the same time achieving higher levels of patient engagement. Health delivery systems should reengineer care delivery to better meet the needs of the population they serve by incorporating new technologies and modes of patient interaction that focus on the real-time, continuous management of chronic conditions.
Statement of Conflict of Interest
None of the authors have any conflicts of interests with regard to this publication. 
